The influence of cardiovascular risk factors on bone marrow mesenchymal stromal cell fitness

References

• Amado LC, Saliaris AP, Schuleri KH, St John M, Xie JS, Cattaneo S, . Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA. 2005;102:11474–9.
   PubMed Web of Science ®Google Scholar
• Dai W, Hale SL, Martin BJ, Kuang JQ, Dow JS, Wold LE, . Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation. 2005;112:214–23.
   PubMed Web of Science ®Google Scholar
• Freyman T, Polin G, Osman H, Crary J, Lu M, Cheng L, . A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J. 2006;27:1114–22.
   PubMed Web of Science ®Google Scholar
• Quevedo HC, Hatzistergos KE, Oskouei BN, Feigenbaum GS, Rodriguez JE, Valdes D, . Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci USA. 2009;106:14022–7.
   PubMed Web of Science ®Google Scholar
• Chen SL, Fang WW, Ye F, Liu YH, Qian J, Shan SJ, . Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol. 2004;94:92–5.
   PubMed Web of Science ®Google Scholar
• Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP, . A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol. 2009;54:2277–86.
   PubMed Web of Science ®Google Scholar
• Choi YH, Kurtz A, Stamm C. Mesenchymal stem cells for cardiac cell therapy. Hum Gene Ther. 2011;22:3–17.
   PubMed Web of Science ®Google Scholar
• Mazhari R, Hare JM. Mechanisms of action of mesenchymal stem cells in cardiac repair: potential influences on the cardiac stem cell niche. Nat Clin Pract Cardiovasc Med. 2007;4(Suppl 1):S21–6.
   Google Scholar
• Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation. 2002;105:93–8.
   PubMed Web of Science ®Google Scholar
• Mareschi K, Ferrero I, Rustichelli D, Aschero S, Gammaitoni L, Aglietta M, . Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow. J Cell Biochem. 2006;97:744–54.
   PubMed Web of Science ®Google Scholar
• Stolzing A, Jones E, McGonagle D, Scutt A. Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev. 2008;129:163–73.
   PubMed Web of Science ®Google Scholar
• Stenderup K, Justesen J, Clausen C, Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone. 2003;33:919–26.
   PubMed Web of Science ®Google Scholar
• Sethe S, Scutt A, Stolzing A. Aging of mesenchymal stem cells. Ageing Res Rev. 2006;5:91–116.
   PubMed Web of Science ®Google Scholar
• Ksiazek K. A comprehensive review on mesenchymal stem cell growth and senescence. Rejuvenation Res. 2009;12:105–16.
   PubMed Web of Science ®Google Scholar
• Cole TJ. Applied logistic regression. D. W. Hosmer and S. Lemeshow. Statistics in Medicine. 1991;10:1162–3.
   Google Scholar
• Wagner W, , Feldmann RE JrSeckinger A, Maurer MH, Wein F, Blake J, . The heterogeneity of human mesenchymal stem cell preparations: evidence from simultaneous analysis of proteomes and transcriptomes. Exp Hematol. 2006;34: 536–48.
   PubMed Web of Science ®Google Scholar
• Wagner W, Ho AD. Mesenchymal stem cell preparations: comparing apples and oranges. Stem Cell Rev. 2007;3: 239–48.
   PubMed Web of Science ®Google Scholar
• Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, . Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315–7.
   PubMed Web of Science ®Google Scholar
• Pontikoglou C, Deschaseaux F, Sensebe L, Papadaki HA. Bone marrow mesenchymal stem cells: biological properties and their role in hematopoiesis and hematopoietic stem cell transplantation. Stem Cell Rev. 2011;7:569–89.
   PubMed Web of Science ®Google Scholar
• Psaltis PJ, Zannettino AC, Worthley SG, Gronthos S. Concise review. Mesenchymal stromal cells: potential for cardiovascular repair. Stem Cells. 2008;26:2201–10.
   PubMed Web of Science ®Google Scholar
• Ringden O, Uzunel M, Rasmusson I, Remberger M, Sundberg B, Lonnies H, . Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation. 2006;81:1390–7.
   PubMed Web of Science ®Google Scholar
• Horwitz EM, Dominici M. How do mesenchymal stromal cells exert their therapeutic benefit? Cytotherapy. 2008;10: 771–4.
   PubMed Web of Science ®Google Scholar
• Stute N, Holtz K, Bubenheim M, Lange C, Blake F, Zander AR. Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. Exp Hematol. 2004;32:1212–25.
   PubMed Web of Science ®Google Scholar
• Shahdadfar A, Fronsdal K, Haug T, Reinholt FP, Brinchmann JE. In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem Cells. 2005;23:1357–66.
   PubMed Web of Science ®Google Scholar
• Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T, . Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med. 2006;355:1199–209.
   PubMed Web of Science ®Google Scholar
• Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, . Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet. 2004;364: 141–8.
   PubMed Web of Science ®Google Scholar
• Li TS, Kubo M, Ueda K, Murakami M, Mikamo A, Hamano K. Impaired angiogenic potency of bone marrow cells from patients with advanced age, anemia, and renal failure. J Thorac Cardiovasc Surg. 2010;139:459–65.
   Google Scholar
• Sun X, Gan Y, Tang T, Zhang X, Dai K. In vitro proliferation and differentiation of human mesenchymal stem cells cultured in autologous plasma derived from bone marrow. Tissue Eng Part A. 2008;14:391–400.
   Google Scholar
• Wagner W, Ho AD, Zenke M. Different facets of aging in human mesenchymal stem cells. Tissue Eng Part B Rev. 2010; 16:445–53.
   PubMed Web of Science ®Google Scholar
• Castro-Malaspina H, Gay RE, Resnick G, Kapoor N, Meyers P, Chiarieri D, . Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood. 1980;56:289–301.
   PubMed Web of Science ®Google Scholar
• Grove GL, Houghton BA, Cochran JW, Kress ED, Cristofalo VJ. Hydrocortisone effects on cell proliferation: specificity of response among various cell types. Cell Biol Int Rep. 1977;1:147–55.
   PubMedGoogle Scholar
• Talbot NC, Powell AM, Caperna TJ. Comparison of colony-formation efficiency of bovine fetal fibroblast cell lines cultured with low oxygen, hydrocortisone, l-carnosine, bFGF, or different levels of FBS. Cloning Stem Cells. 2004;6: 37–47.
   Google Scholar
• Li TS, Kubo M, Ueda K, Murakami M, Ohshima M, Kobayashi T, . Identification of risk factors related to poor angiogenic potency of bone marrow cells from different patients. Circulation. 2009;120:S255–61.
   Google Scholar
• Stolzing A, Sellers D, Llewelyn O, Scutt A. Diabetes induced changes in rat mesenchymal stem cells. Cells Tissues Organs. 2010;191:453–65. Epub 2010 Feb 3.
   PubMed Web of Science ®Google Scholar
• Togel F, Cohen A, Zhang P, Yang Y, Hu Z, Westenfelder C. Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury. Stem Cells Dev. 2009;18:475–85.
   PubMed Web of Science ®Google Scholar
• Choi S, Park M, Kim J, Hwang S, Park S, Lee Y. The role of mesenchymal stem cells in the functional improvement of chronic renal failure. Stem Cells Dev. 2009;18:521–9.
   PubMed Web of Science ®Google Scholar
• Urban VS, Kiss J, Kovacs J, Gocza E, Vas V, Monostori E, . Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes. Stem Cells. 2008;26:244–53.
   PubMed Web of Science ®Google Scholar
• Lee JW, Gupta N, Serikov V, Matthay MA. Potential application of mesenchymal stem cells in acute lung injury. Expert Opin Biol Ther. 2009;9:1259–70.
   PubMed Web of Science ®Google Scholar